tried to correct a metabolic liver disease in mice (ornithine transcarbamylase [OTC] deficiency) by intravenously infusing two AAVs, one expressing Cas9 and the other expressing a guide RNA, and the donor OTC DNA sequence.82 The gene discussed is OTC; the disease is ornithine carbamoyltransferase deficiency.